Main Analysis of Semaglutide OW Comparative Effectiveness with SGLT2is The subset of patients initiating semaglutide OW who did not have baseline or follow-up use of SGLT2i were identified, characterized, and compared with patients initiating SGLT2i after inverse probability of treatment weighting (IPTW), for changes in weight, BMI, HbA1c, composite weight and HbA1c outcomes, all-cause HCRU, and medical costs
Research suggests that approximately 3% of patients on the 0.5 mg dose and around 1% of those on the 1 mg dose of Ozempic reported experiencing burping as a side effect
Ready to reclaim your confidence and achieve your weight loss goals
But it is patients with the lowest disposable incomes who are being hit the hardest
Muscle mass: Preserving muscle mass during GLP-1 mediated weight loss requires deliberate attention to protein intake and resistance training
A protein shake takes 30 seconds to drink and delivers 25 to 30 grams without requiring you to chew, taste, or think about food for very long
